Schedule 13G ownership disclosure

KEZAR LIFE SCIENCES INC

Common Stock · CUSIP: 49372L209

Event date: 2025-09-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Stonepine Capital Management, LLC

    Shares: 377,240.00 · Class: 5.2%

  • Stonepine Capital, L.P.

    Shares: 377,240.00 · Class: 5.2%

  • Stonepine GP, LLC

    Shares: 377,240.00 · Class: 5.2%

  • Jon M. Plexico

    Shares: 377,240.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000592
Form type
SCHEDULE 13G
Filer
Kezar Life Sciences, Inc.
CIK
CIK 1645666
Filed
Sep 08, 2025
Reporting period
Sep 02, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub